Blinatumomab and Tyrosine Kinase Inhibitor Therapy in People With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
Conditions: Acute Lymphoblastic Leukemia; Philadelphia Chromosome-Positive Interventions: Drug: Blinatumomab; Procedure: Bone marrow aspiration and biopsy (BMA); Drug: corticosteroids Sponsors: Memorial Sloan Kettering Cancer Center; Amgen Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials